The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 11, Pages 3206
Publisher
MDPI AG
Online
2021-11-17
DOI
10.3390/cells10113206
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
- (2020) John Y. L. Chiang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Rapid Postnatal Upregulation of Intestinal FXR-FGF19 Signalling in Premature Pigs
- (2020) Victoria Smith et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease
- (2020) Aze Wilson et al. Scientific Reports
- Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation
- (2020) Mengque Xu et al. DIGESTIVE DISEASES AND SCIENCES
- Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids
- (2020) Jenessa A. Winston et al. INFECTION AND IMMUNITY
- Farnesoid X receptor knockout protects brain against ischemic injury through reducing neuronal apoptosis in mice
- (2020) Hui-Min Shan et al. Journal of Neuroinflammation
- Intestinal Inflammation Alters the Expression of Hepatic Bile Acid Receptors Causing Liver Impairment
- (2020) Anna Negroni et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor
- (2020) Raffaella Maria Gadaleta et al. EBioMedicine
- Genetic variation in the farnesoid X-receptor predicts Crohn’s disease severity in female patients
- (2020) Aze Wilson et al. Scientific Reports
- Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells
- (2020) Teerasak Wongwan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chenodeoxycholic Acid Releases Proinflammatory Cytokines from Small Intestinal Epithelial Cells Through the Farnesoid X Receptor
- (2019) Tomoki Horikawa et al. DIGESTION
- FXR Regulates Intestinal Cancer Stem Cell Proliferation
- (2019) Ting Fu et al. CELL
- FxR-modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis
- (2019) M. Sorribas et al. JOURNAL OF HEPATOLOGY
- Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier Function via the FXR-MLCK Pathway
- (2019) Min Song et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Farnesoid X Receptor (FXR) Aggravates Amyloid-β-Triggered Apoptosis by Modulating the cAMP-Response Element-Binding Protein (CREB)/Brain-Derived Neurotrophic Factor (BDNF) Pathway In Vitro
- (2019) Qingfa Chen et al. MEDICAL SCIENCE MONITOR
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non–Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers
- (2019) Michael K. Badman et al. Clinical Pharmacology in Drug Development
- The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing
- (2018) Magdalena S. Mroz et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Molecular cloning and characterization of farnesoid X receptor from large yellow croaker ( Larimichthys crocea ) and the effect of dietary CDCA on the expression of inflammatory genes in intestine and spleen
- (2018) Jianlong Du et al. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
- Update on FXR Biology: Promising Therapeutic Target?
- (2018) Chang Han INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Progress and challenges of selective Farnesoid X Receptor modulation
- (2018) Vittoria Massafra et al. PHARMACOLOGY & THERAPEUTICS
- Hippocampal FXR plays a role in the pathogenesis of depression: A preliminary study based on lentiviral gene modulation
- (2018) Wei-Guan Chen et al. PSYCHIATRY RESEARCH
- The Intestinal Epithelium: Central Coordinator of Mucosal Immunity
- (2018) Joannie M. Allaire et al. TRENDS IN IMMUNOLOGY
- Farnesoid X receptor agonist obeticholic acid inhibits renal inflammation and oxidative stress during lipopolysaccharide-induced acute kidney injury
- (2018) Jin-Bo Zhu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Obeticholic acid alleviate lipopolysaccharide-induced acute lung injury via its anti-inflammatory effects in mice
- (2018) Jun Fei et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- A rapid administration of GW4064 inhibits the NLRP3 inflammasome activation independent of farnesoid X receptor agonism
- (2017) Shujun Xie et al. FEBS LETTERS
- Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease
- (2017) Oscar Chávez-Talavera et al. GASTROENTEROLOGY
- Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis
- (2017) Paolo Comeglio et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
- (2017) Wei Jia et al. Nature Reviews Gastroenterology & Hepatology
- Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats
- (2017) Laurens J. Ceulemans et al. PLoS One
- Activation of the Nuclear Receptor Fxr Improves Intestinal Cell Tolerance to Ischemia–reperfusion Injury
- (2017) Xuan Wang et al. SHOCK
- Cell Biology of Tight Junction Barrier Regulation and Mucosal Disease
- (2017) Aaron Buckley et al. Cold Spring Harbor Perspectives in Biology
- Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling
- (2016) Avafia Y. Dossa et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Splenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis
- (2016) Vittoria Massafra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- Farnesoid X receptor regulates vasoreactivity via Angiotensin II type 2 receptor and the kallikrein-kinin system in vascular endothelial cells
- (2016) Ran Zhang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Identification of functional farnesoid X receptors in brain neurons
- (2016) Chao Huang et al. FEBS LETTERS
- Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation
- (2016) Monika Rau et al. INFLAMMATORY BOWEL DISEASES
- Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats
- (2016) María Úbeda et al. JOURNAL OF HEPATOLOGY
- Fatty liver diseases, bile acids, and FXR
- (2016) Yan Zhu et al. Acta Pharmaceutica Sinica B
- The Impact of Farnesoid X Receptor Activation on Intestinal Permeability in Inflammatory Bowel Disease
- (2016) Maja Stojancevic et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy
- (2016) Cinzia Giordano et al. Scientific Reports
- The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
- (2015) Len Verbeke et al. AMERICAN JOURNAL OF PATHOLOGY
- Nuclear bile acid signaling through the farnesoid X receptor
- (2014) Claire Mazuy et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Role of farnesoid X receptor in inflammation and resolution
- (2014) Firdose Begum Shaik et al. INFLAMMATION RESEARCH
- Transcriptional Regulation of the Intestinal Nuclear Bile Acid Farnesoid X Receptor (FXR) by the caudal-related Homeobox 2 (CDX2)
- (2014) Salvatore Modica et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis
- (2014) Xueyan Zhou et al. Nature Communications
- Positive regulation of osteogenesis by bile acid through FXR
- (2013) Sun Wook Cho et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bile acid receptors as targets for drug development
- (2013) Frank G. Schaap et al. Nature Reviews Gastroenterology & Hepatology
- FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents
- (2013) Barbara Renga et al. PHARMACOLOGICAL RESEARCH
- The Bile Acid Sensor FXR Is Required for Immune-Regulatory Activities of TLR-9 in Intestinal Inflammation
- (2013) Barbara Renga et al. PLoS One
- Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms
- (2012) Danielle A.A. Hollman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Src-Mediated Cross-Talk between Farnesoid X and Epidermal Growth Factor Receptors Inhibits Human Intestinal Cell Proliferation and Tumorigenesis
- (2012) Zhongsheng Peng et al. PLoS One
- Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine
- (2011) Raffaella M. Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice
- (2011) Stefano Fiorucci et al. BRITISH JOURNAL OF PHARMACOLOGY
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
- (2011) Rian M. Nijmeijer et al. PLoS One
- Bile salt supplementation acts via the farnesoid X receptor to alleviate lipopolysaccharide-induced intestinal injury
- (2011) Hamid R. Zahiri et al. SURGERY
- Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
- (2010) G. Rizzo et al. MOLECULAR PHARMACOLOGY
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-γ-STAT-1 pathway in macrophages
- (2009) Barbara Renga et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- FXR an emerging therapeutic target for the treatment of atherosclerosis
- (2009) Andrea Mencarelli et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
- (2009) P. Vavassori et al. JOURNAL OF IMMUNOLOGY
- Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation
- (2009) Barbara Renga et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Farnesoid X Receptor Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development
- (2008) R. R.M. Maran et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started